Belpointe Asset Management LLC Trims Stake in GE HealthCare Technologies Inc. $GEHC

Belpointe Asset Management LLC reduced its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 46.2% during the second quarter, HoldingsChannel.com reports. The firm owned 9,673 shares of the company’s stock after selling 8,294 shares during the period. Belpointe Asset Management LLC’s holdings in GE HealthCare Technologies were worth $716,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Glenview Trust co boosted its stake in shares of GE HealthCare Technologies by 4.4% during the first quarter. Glenview Trust co now owns 3,294 shares of the company’s stock valued at $266,000 after purchasing an additional 139 shares in the last quarter. Silver Oak Securities Incorporated boosted its stake in shares of GE HealthCare Technologies by 4.6% during the second quarter. Silver Oak Securities Incorporated now owns 3,183 shares of the company’s stock valued at $236,000 after purchasing an additional 140 shares in the last quarter. Chicago Capital LLC boosted its stake in shares of GE HealthCare Technologies by 2.2% during the second quarter. Chicago Capital LLC now owns 6,551 shares of the company’s stock valued at $485,000 after purchasing an additional 141 shares in the last quarter. Fort Washington Investment Advisors Inc. OH boosted its stake in shares of GE HealthCare Technologies by 4.2% during the second quarter. Fort Washington Investment Advisors Inc. OH now owns 3,557 shares of the company’s stock valued at $263,000 after purchasing an additional 143 shares in the last quarter. Finally, Knuff & Co LLC boosted its stake in shares of GE HealthCare Technologies by 1.5% during the first quarter. Knuff & Co LLC now owns 10,276 shares of the company’s stock valued at $829,000 after purchasing an additional 150 shares in the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Up 0.9%

NASDAQ GEHC opened at $75.13 on Thursday. The company has a fifty day simple moving average of $74.22 and a two-hundred day simple moving average of $72.47. The stock has a market cap of $34.30 billion, a P/E ratio of 15.40, a P/E/G ratio of 2.85 and a beta of 1.13. GE HealthCare Technologies Inc. has a 12-month low of $57.65 and a 12-month high of $94.80. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.91 by $0.15. The business had revenue of $5 billion during the quarter, compared to analysts’ expectations of $4.96 billion. GE HealthCare Technologies had a net margin of 11.22% and a return on equity of 23.93%. The business’s quarterly revenue was up 3.5% on a year-over-year basis. During the same quarter last year, the company posted $1.00 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. On average, analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be issued a $0.035 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is currently 2.87%.

Analyst Upgrades and Downgrades

GEHC has been the subject of several recent analyst reports. Weiss Ratings restated a “hold (c)” rating on shares of GE HealthCare Technologies in a research note on Saturday, September 27th. Citigroup downgraded shares of GE HealthCare Technologies from a “buy” rating to a “neutral” rating and lowered their target price for the company from $93.00 to $83.00 in a research note on Tuesday. BTIG Research restated a “buy” rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Zacks Research downgraded shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research note on Monday, September 29th. Finally, Morgan Stanley set a $74.00 target price on shares of GE HealthCare Technologies in a research note on Thursday, September 18th. Six analysts have rated the stock with a Buy rating and five have given a Hold rating to the stock. According to data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average target price of $85.78.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.